[HTML] thelancet.com

[HTML][HTML] Anakinra in COVID-19: important considerations for clinical trials

A King, A Vail, C O'Leary, C Hannan… - The Lancet …, 2020 - thelancet.com
The COVID-19 pandemic caused by the severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) has caused more than 320 000 deaths as of May 19, 2020. COVID-19 deaths …
被引用次数：53 相关文章

Anakinra in COVID-19: important considerations for clinical trials

A King, A Vail, C O'Leary, C Hannan… - The Lancet …, 2020 - pubmed.ncbi.nlm.nih.gov
Anakinra in COVID-19: important considerations for clinical trials Anakinra in COVID-19:
important considerations for clinical trials Lancet Rheumatol. 2020 Jul;2(7):e379-e381. doi …
[HTML] nih.gov

[HTML][HTML] Anakinra in COVID-19: important considerations for clinical trials

A King, A Vail, C O'Leary, C Hannan… - The Lancet …, 2020 - ncbi.nlm.nih.gov
The COVID-19 pandemic caused by the severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) has caused more than 320 000 deaths as of May 19, 2020. COVID-19 deaths …

Anakinra in COVID-19: important considerations for clinical trials.

A King, A Vail, C O'Leary, C Hannan… - The Lancet …, 2020 - europepmc.org
The COVID-19 pandemic caused by the severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) has caused more than 320 000 deaths as of May 19, 2020. COVID-19 deaths …

[引用][C] Anakinra in COVID-19: important considerations for clinical trials

A King, A Vail, C O'Leary, C Hannan… - The Lancet …, 2020 - research.manchester.ac.uk
Anakinra in COVID-19: important considerations for clinical trials — Research Explorer The
University of Manchester Skip to main navigation Skip to search Skip to main content Research …

Anakinra in COVID-19: important considerations for clinical trials.

A King, A Vail, C O'Leary, C Hannan… - The Lancet …, 2020 - europepmc.org
The COVID-19 pandemic caused by the severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) has caused more than 320 000 deaths as of May 19, 2020. COVID-19 deaths …